SPRR3 and metabolic dysfunction-associated steatotic liver disease: Overall, our results clearly showed that SPRC not only alleviated MCD diet-induced NAFLD, but also attenuated OA-induced ROS level in HepG2 cells, which indicated that SPRC could be useful for the treatment of NAFLD.